Science ❯Biotechnology
Vaccines Vaccine Technology Health Policies Pharmaceutical Companies Pandemic Preparedness Clinical Trials Public Health Policy Moderna Public Health Response Department of Health and Human Services
Health Secretary Robert F. Kennedy Jr.’s mistrust of mRNA platforms prompted the decision despite promising Phase 1/2 data for the H5N1 project.
